---
title: "Abbott Laboratories Stock Outperforms Competitors On Strong Trading Day"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/296650785.md"
description: "Abbott Laboratories (ABT) shares rose 2.19% to $116.64 on a positive trading day, outperforming the broader market's gains. The S&P 500 and Dow Jones also closed higher. Abbott remains 15.16% below its 52-week high of $137.49. While competitors like Johnson & Johnson, Pfizer, and Merck saw modest gains, Abbott's performance was mixed relative to peers. Trading volume was lower than the 50-day average."
datetime: "2026-08-21T20:34:15.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/296650785.md)
  - [en](https://longbridge.com/en/news/296650785.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/296650785.md)
generator: "portal-rs"
---

# Abbott Laboratories Stock Outperforms Competitors On Strong Trading Day

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of Abbott Laboratories (ABT) rose 2.19% to $116.64 Friday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index rising 0.43% to 7,674.37 and the Dow Jones Industrial Average rising 0.98% to 53,277.01.

Abbott Laboratories closed 15.16% short of its 52-week high of $137.49, which the company reached on September 22nd.

The stock demonstrated a mixed performance when compared to some of its competitors Friday, as Johnson & Johnson (JNJ) rose 1.07% to $270.24, Pfizer Inc. (PFE) rose 1.01% to $28.07, and Merck & Co. Inc. (MRK) rose 2.39% to $152.55.

Trading volume (9.8 M) remained 2.1 million below its 50-day average volume of 11.9 M.

Data source: Dow Jones Market Data, FactSet. Data compiled August 21, 2026.

This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.

(END) Dow Jones Newswires

08-21-26 1634ET

### Related Stocks

- [ABT.US](https://longbridge.com/en/quote/ABT.US.md)
- [.SPX.US](https://longbridge.com/en/quote/.SPX.US.md)
- [.DJI.US](https://longbridge.com/en/quote/.DJI.US.md)
- [JNJ.US](https://longbridge.com/en/quote/JNJ.US.md)
- [PFE.US](https://longbridge.com/en/quote/PFE.US.md)
- [MRK.US](https://longbridge.com/en/quote/MRK.US.md)

## Related News & Research

- [Xcel Wealth Management LLC Cuts Stock Holdings in Abbott Laboratories $ABT](https://longbridge.com/en/news/296700328.md)
- [Murphy Pohlad Asset Management LLC Purchases 12,140 Shares of Abbott Laboratories $ABT](https://longbridge.com/en/news/296461096.md)
- [Did Abbott’s Q2 Beat and Profit Hike Just Shift Abbott Laboratories’ (ABT) Investment Narrative?](https://longbridge.com/en/news/296546525.md)
- [Jefferies Sticks to Their Buy Rating for Abbott Laboratories (ABT)](https://longbridge.com/en/news/296645903.md)
- [True North Advisors LLC Trims Stake in Abbott Laboratories $ABT](https://longbridge.com/en/news/296590047.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**